Ballwin, MO, United States of America

Mark A Massa

This inventor holds 40 USPTO granted patents, primarily in Cholesterol Inhibition. Top assignees: Pharmacia Corporation, G.d. Searle & Company, Pfizer Corporation. Active years: 2000-2012.


% Patents Active = 7.5

Average Co-Inventor Count = 14.5

ph-index = 8

Forward Citations = 193(Granted Patents)


Location History:

  • Ballwin, MI (US) (2004)
  • Ballwin, MO (US) (2000 - 2010)
  • Chesterfield, MO (US) (2012)

Company Filing History:


Years Active: 2000-2012

Loading Chart...
Areas of Expertise:
Cholesterol Ester Transfer Protein
Pyrazole Derivatives
Amino Compounds
Protease Inhibitors
Nitric Oxide Synthase
Heterocyclic Amino Compounds
Aminoalcohol Compounds
Sulfonylmethyl Hydroxamic Acids
Cycloalkyl Aminoalcohols
Chiral Halogenated Compounds
Fused Heterocyclic Compounds
Tertiary-Heteroalkylamines
40 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mark A. Massa

Introduction:

Mark A. Massa, a talented inventor hailing from Ballwin, Missouri, has made significant contributions to the world of innovation with his creative mind and dedication to progress.

Latest Patents:

Mark A. Massa's latest patents showcase his commitment to pushing boundaries and exploring new possibilities in various industries.

Career Highlights:

Throughout his illustrious career, Mark A. Massa has demonstrated a keen ability to transform ideas into tangible inventions that have the potential to revolutionize the way we live and work.

Collaborations:

Mark A. Massa has collaborated with leading experts in the field, leveraging their knowledge and expertise to bring his innovative concepts to life and make a lasting impact on society.

Conclusion:

In conclusion, Mark A. Massa's passion for innovation and his relentless pursuit of excellence have solidified his position as a respected inventor in the industry, with a bright future ahead.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…